News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
75 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Deals
Takeda Announces Information Related to its Pending Voluntary and Conditional Public Takeover Bid for Outstanding Shares and American Depositary Shares of TiGenix
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced information related to its previously announced and ongoing tender offer (the “Bid”) in cash for all outstanding ordinary shares (“Ordinary Shares”), warrants (“Warrants”) and American Depositary Shares (“ADSs”) of TiGenix.
May 23, 2018
·
9 min read
Business
Mainstay Medical Announces CFO Transition
Mainstay Medical International plc announces that Mr. Hugh Kavanagh is to step down as Chief Financial Officer (“CFO”) and leave Mainstay with effect from 21 August 2018.
May 23, 2018
·
5 min read
Grail Raises $300 Million from China Investors for Early Cancer Diagnostics
Grail announced a $300 million C financing. Since early 2016, Grail has raised over $1.5 billion.
May 23, 2018
·
1 min read
Business
OncoDNA announces screening collaboration with Kura Oncology
OncoDNA is pleased to announce that it has signed a screening agreement with Kura Oncology, Inc.
May 23, 2018
·
4 min read
Biotech Beach
MDxHealth (R): Presentation of New Data on MDxHealth’s Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting
MDxHealth SA announces that significant data on the performance of its SelectMDx, and ConfirmMDx tests for prostate cancer and AssureMDx test for bladder cancer were presented in two moderated posters and one podium presentation at the American Urological (AUA) Annual Meeting 18-21 May in San Francisco.
May 23, 2018
·
4 min read
MedAlliance Raises $37 Million to Launch Sirolimus Drug-Coated Balloon
M.A. MedAlliance SA has raised $37 million.
May 23, 2018
·
3 min read
Presentation of New Data on MDxHealth’s Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting
MDxHealth SA announces that significant data on the performance of its SelectMDx, and ConfirmMDx tests for prostate cancer and AssureMDx test for bladder cancer were presented in two moderated posters and one podium presentation at the American Urological (AUA) Annual Meeting 18-21 May in San Francisco.
May 23, 2018
·
4 min read
BioForest
Achieve Life Sciences, Inc. Announces Reverse Stock Split
Reverse stock split of its shares of common stock at a ratio of 1-for-10.
May 23, 2018
·
4 min read
Drug Development
Webcast Alert: Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of Stockholders
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present a general corporate update in conjunction with its 2018 Annual Meeting of Stockholders and Open House on Wednesday, May 23 at 2:10 p.m. Pacific Time (5:10 p.m. Eastern Time) in Carlsbad, CA.
May 23, 2018
·
3 min read
Pharm Country
PAVmed Updates Expected Key Dates for Previously Announced Rights Offering
Company had filed a preliminary prospectus as part of a registration statement on Form S-1 with the Securities and Exchange Commission for a rights offering to stockholders of record on Monday, May 21, 2018.
May 23, 2018
·
3 min read
Previous
4 of 8
Next